Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

eHealth (EHTH) Research & Development (2016 - 2025)

eHealth (EHTH) has 14 years of Research & Development data on record, last reported at $12.6 million in Q1 2025.

  • For Q1 2025, Research & Development fell 5.29% year-over-year to $12.6 million; the TTM value through Mar 2025 reached $69.5 million, down 1.1%, while the annual FY2025 figure was $51.8 million, 3.16% down from the prior year.
  • Research & Development reached $12.6 million in Q1 2025 per EHTH's latest filing, down from $13.3 million in the prior quarter.
  • Across five years, Research & Development topped out at $23.2 million in Q1 2021 and bottomed at $12.6 million in Q1 2025.
  • Average Research & Development over 3 years is $17.4 million, with a median of $16.9 million recorded in 2021.
  • Peak YoY movement for Research & Development: skyrocketed 53.02% in 2021, then dropped 5.29% in 2025.
  • A 3-year view of Research & Development shows it stood at $20.5 million in 2021, then tumbled by 34.98% to $13.3 million in 2024, then dropped by 5.29% to $12.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Research & Development were $12.6 million in Q1 2025, $13.3 million in Q1 2024, and $20.5 million in Q2 2021.